ELIOT D FOLEY

Allopathic & Osteopathic Physicians|Ophthalmology|Retina Specialist MANCHESTER, NH NPI 1528069424

General Payments — all program years on this page

$1,256.72

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 58
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $393.04 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $375.8518
Education $17.191

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $88.522
2019 $360.2213
2020 $91.555
2021 $112.677
2022 $66.084
2023 $144.648
2024 $393.0419

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1092828147 Alimera Sciences, Inc. $20.75 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092831964 Alimera Sciences, Inc. $18.46 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092834860 Alimera Sciences, Inc. $23.44 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114048935 Regeneron Healthcare Solutions, Inc. $19.43 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114048937 Regeneron Healthcare Solutions, Inc. $35.20 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117554889 Amgen Inc. $14.22 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133006080 Genentech USA, Inc. $18.83 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133006084 Genentech USA, Inc. $23.04 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133006088 Genentech USA, Inc. $19.18 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133006092 Genentech USA, Inc. $23.92 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133006096 Genentech USA, Inc. $21.29 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133006100 Genentech USA, Inc. $15.84 11/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139352459 Astellas Pharma US Inc $34.90 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139353203 Astellas Pharma US Inc $14.69 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140339438 Bausch & Lomb Americas Inc. $24.98 12/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147411295 Oyster Point Pharma, Inc. $19.25 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152146078 SUN PHARMACEUTICAL INDUSTRIES INC. $15.12 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154020597 Apellis Pharmaceuticals, Inc. $13.31 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154020599 Apellis Pharmaceuticals, Inc. $17.19 01/09/2024 Education Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.